NCT00375310 Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00369473 Long-Term Assessment of Safety and Physical Function With AMG 108 in RA Status COMPLETED Phase PHASE2
NCT00369070 A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC Status TERMINATED Phase PHASE2
NCT00364845 STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients Status TERMINATED Phase PHASE3
NCT00364013 PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy Status COMPLETED Phase PHASE3
NCT00361634 Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT00359047 Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme Status ACTIVE_NOT_RECRUITING Phase NA
NCT00358215 RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial Status COMPLETED Phase PHASE3
NCT00357903 Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials Status COMPLETED Phase PHASE3
NCT00356681 A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer Status TERMINATED Phase PHASE2
NCT00356590 Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012 Status COMPLETED Phase PHASE3
NCT00355407 Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation Status COMPLETED Phase NA
NCT00353119 A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis Status COMPLETED Phase PHASE3
NCT00352950 Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE1